Awaiting development: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Area of interest

Area of interest

Type

Type

Guidance programme 1 selected

Guidance programme

Showing 291 to 291 of 291

TitleType
Zongertinib for treating HER2-mutated unresectable or metastatic non-small-cell lung cancer [ID6573]Technology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All